164 related articles for article (PubMed ID: 12365005)
1. Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy.
Scott SD; Joiner MC; Marples B
Gene Ther; 2002 Oct; 9(20):1396-402. PubMed ID: 12365005
[TBL] [Abstract][Full Text] [Related]
2. Development of synthetic promoters for radiation-mediated gene therapy.
Marples B; Scott SD; Hendry JH; Embleton MJ; Lashford LS; Margison GP
Gene Ther; 2000 Mar; 7(6):511-7. PubMed ID: 10757025
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
Greco O; Powell TM; Marples B; Joiner MC; Scott SD
Cancer Gene Ther; 2005 Jul; 12(7):655-62. PubMed ID: 15818381
[TBL] [Abstract][Full Text] [Related]
5. Novel, chimeric, cancer-specific, and radiation-inducible gene promoters for suicide gene therapy of cancer.
Xiong J; Sun WJ; Wang WF; Liao ZK; Zhou FX; Kong HY; Xu Y; Xie CH; Zhou YF
Cancer; 2012 Jan; 118(2):536-48. PubMed ID: 21717442
[TBL] [Abstract][Full Text] [Related]
6. [Anti-tumor effect of suicide gene therapy using chimeric promoter plus radiotherapy on cancer cell lines].
Sun WJ; Xiong J; Wang WF; Liao ZK; Zhou FX; Zhou YF
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):245-50. PubMed ID: 21575492
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a synthetic CArG promoter for nitric oxide synthase gene therapy of cancer.
Worthington J; Robson T; Scott S; Hirst D
Gene Ther; 2005 Oct; 12(19):1417-23. PubMed ID: 15902277
[TBL] [Abstract][Full Text] [Related]
8. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
[TBL] [Abstract][Full Text] [Related]
9. [Oncostatin M gene therapy in mice bearing lung adenocarcinoma xenograft using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):240-3. PubMed ID: 15144614
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
11. The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.
Coulter JA; McCarthy HO; Worthington J; Robson T; Scott S; Hirst DG
Gene Ther; 2008 Apr; 15(7):495-503. PubMed ID: 18256696
[TBL] [Abstract][Full Text] [Related]
12. Activation of stress-responsive promoters by ionizing radiation for deployment in targeted gene therapy.
Chastel C; Jiricny J; Jaussi R
DNA Repair (Amst); 2004 Mar; 3(3):201-15. PubMed ID: 15177036
[TBL] [Abstract][Full Text] [Related]
13. Development of artificial chimerical gene regulatory elements specific for cancer gene therapy.
Shin JH; Yi JK; Lee YJ; Kim AL; Park MA; Kim SH; Lee H; Kim CG
Oncol Rep; 2003; 10(6):2063-9. PubMed ID: 14534744
[TBL] [Abstract][Full Text] [Related]
14. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O
Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771
[TBL] [Abstract][Full Text] [Related]
15. The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells.
Shi CX; Long MA; Liu L; Graham FL; Gauldie J; Hitt MM
Mol Ther; 2004 Oct; 10(4):758-67. PubMed ID: 15451460
[TBL] [Abstract][Full Text] [Related]
16. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements.
de Leeuw B; Su M; ter Horst M; Iwata S; Rodijk M; Hoeben RC; Messing A; Smitt PS; Brenner M
J Neurosci Res; 2006 Apr; 83(5):744-53. PubMed ID: 16496373
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
19. Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter.
Hsu H; Rainov NG; Quinones A; Eling DJ; Sakamoto KM; Spear MA
Anticancer Res; 2003; 23(3B):2723-8. PubMed ID: 12894565
[TBL] [Abstract][Full Text] [Related]
20. Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers.
Modlich U; Pugh CW; Bicknell R
Gene Ther; 2000 May; 7(10):896-902. PubMed ID: 10845728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
